Literature DB >> 19960040

Macrophage death and defective inflammation resolution in atherosclerosis.

Ira Tabas1.   

Abstract

A key event in atherosclerosis is a maladaptive inflammatory response to subendothelial lipoproteins. A crucial aspect of this response is a failure to resolve inflammation, which normally involves the suppression of inflammatory cell influx, effective clearance of apoptotic cells and promotion of inflammatory cell egress. Defects in these processes promote the progression of atherosclerotic lesions into dangerous plaques, which can trigger atherothrombotic vascular disease, the leading cause of death in industrialized societies. In this Review I provide an overview of these concepts, with a focus on macrophage death and defective apoptotic cell clearance, and discuss new therapeutic strategies designed to boost inflammation resolution in atherosclerosis.

Entities:  

Mesh:

Year:  2009        PMID: 19960040      PMCID: PMC2854623          DOI: 10.1038/nri2675

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  130 in total

Review 1.  Alternative activation of macrophages: an immunologic functional perspective.

Authors:  Fernando O Martinez; Laura Helming; Siamon Gordon
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

Review 2.  Mechanisms and consequences of macrophage apoptosis in atherosclerosis.

Authors:  Tracie Seimon; Ira Tabas
Journal:  J Lipid Res       Date:  2008-10-25       Impact factor: 5.922

Review 3.  Emerging role of Toll-like receptors in atherosclerosis.

Authors:  Linda K Curtiss; Peter S Tobias
Journal:  J Lipid Res       Date:  2008-11-01       Impact factor: 5.922

4.  Macrophage deficiency of p38alpha MAPK promotes apoptosis and plaque necrosis in advanced atherosclerotic lesions in mice.

Authors:  Tracie A Seimon; Yibin Wang; Seongah Han; Takafumi Senokuchi; Dorien M Schrijvers; George Kuriakose; Alan R Tall; Ira A Tabas
Journal:  J Clin Invest       Date:  2009-03-16       Impact factor: 14.808

5.  Oxidized low-density lipoproteins trigger endoplasmic reticulum stress in vascular cells: prevention by oxygen-regulated protein 150 expression.

Authors:  Marie Sanson; Nathalie Augé; Cécile Vindis; Carole Muller; Yoshio Bando; Jean-Claude Thiers; Marie-Agnès Marachet; Kamelija Zarkovic; Yoshiki Sawa; Robert Salvayre; Anne Nègre-Salvayre
Journal:  Circ Res       Date:  2008-12-23       Impact factor: 17.367

6.  Milk fat globule epidermal growth factor-factor VIII is down-regulated in sepsis via the lipopolysaccharide-CD14 pathway.

Authors:  Hidefumi Komura; Michael Miksa; Rongqian Wu; Sanna M Goyert; Ping Wang
Journal:  J Immunol       Date:  2009-01-01       Impact factor: 5.422

Review 7.  Interleukin-10: new perspectives on an old cytokine.

Authors:  David M Mosser; Xia Zhang
Journal:  Immunol Rev       Date:  2008-12       Impact factor: 12.988

Review 8.  Cannabinoids, endocannabinoids, and related analogs in inflammation.

Authors:  Sumner H Burstein; Robert B Zurier
Journal:  AAPS J       Date:  2009-02-06       Impact factor: 4.009

9.  Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions.

Authors:  Charles N Serhan; Rong Yang; Kimberly Martinod; Kie Kasuga; Padmini S Pillai; Timothy F Porter; Sungwhan F Oh; Matthew Spite
Journal:  J Exp Med       Date:  2008-12-22       Impact factor: 14.307

10.  Macrophage phagocytosis of apoptotic neutrophils is critically regulated by the opposing actions of pro-inflammatory and anti-inflammatory agents: key role for TNF-alpha.

Authors:  Sylwia Michlewska; Ian Dransfield; Ian L Megson; Adriano G Rossi
Journal:  FASEB J       Date:  2008-10-29       Impact factor: 5.191

View more
  437 in total

1.  Regulator of G-protein signalling 5 protects against atherosclerosis in apolipoprotein E-deficient mice.

Authors:  Wen-Lin Cheng; Pi-Xiao Wang; Tao Wang; Yan Zhang; Cheng Du; Hongliang Li; Yong Ji
Journal:  Br J Pharmacol       Date:  2015-01-12       Impact factor: 8.739

Review 2.  Macrophage subsets in atherosclerosis.

Authors:  Giulia Chinetti-Gbaguidi; Sophie Colin; Bart Staels
Journal:  Nat Rev Cardiol       Date:  2014-11-04       Impact factor: 32.419

3.  How does interferon-α insult the vasculature? Let me count the ways.

Authors:  Mariana J Kaplan; Jane E Salmon
Journal:  Arthritis Rheum       Date:  2011-02

4.  Nanoparticle Functionalization with Platelet Membrane Enables Multifactored Biological Targeting and Detection of Atherosclerosis.

Authors:  Xiaoli Wei; Man Ying; Diana Dehaini; Yuanyuan Su; Ashley V Kroll; Jiarong Zhou; Weiwei Gao; Ronnie H Fang; Shu Chien; Liangfang Zhang
Journal:  ACS Nano       Date:  2017-12-12       Impact factor: 15.881

Review 5.  Sex differences in stroke.

Authors:  Roy A M Haast; Deborah R Gustafson; Amanda J Kiliaan
Journal:  J Cereb Blood Flow Metab       Date:  2012-10-03       Impact factor: 6.200

Review 6.  Macrophages clean up: efferocytosis and microbial control.

Authors:  Constance J Martin; Kristen N Peters; Samuel M Behar
Journal:  Curr Opin Microbiol       Date:  2013-12-05       Impact factor: 7.934

Review 7.  Non-coding RNA regulation of endothelial and macrophage functions during atherosclerosis.

Authors:  Binod Aryal; Yajaira Suárez
Journal:  Vascul Pharmacol       Date:  2018-03-15       Impact factor: 5.773

Review 8.  Immunological aspects of atherosclerosis.

Authors:  S Garrido-Urbani; M Meguenani; F Montecucco; B A Imhof
Journal:  Semin Immunopathol       Date:  2013-11-09       Impact factor: 9.623

9.  Ribosomal protein L13a deficiency in macrophages promotes atherosclerosis by limiting translation control-dependent retardation of inflammation.

Authors:  Abhijit Basu; Darshana Poddar; Peggy Robinet; Jonathan D Smith; Maria Febbraio; William M Baldwin; Barsanjit Mazumder
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-01-16       Impact factor: 8.311

10.  Proliferating macrophages populate established atherosclerotic lesions.

Authors:  Andrew J Murphy; Alan R Tall
Journal:  Circ Res       Date:  2014-01-17       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.